Effects of Consuming Protein Shakes, Varying in Protein Source, on Appetite, Satiety and Energy Intake
NCT ID: NCT03132376
Last Updated: 2017-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-06-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake: A Clinical Screening Study
NCT03595436
The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake
NCT03154606
The Effect of Breakfasts Varying in Protein Source on Appetite and Energy Intake
NCT02573194
Protein Source, Nutrition Messaging, and Food Intake
NCT03083145
Impact of Protein Content of Milk on Post-Exercise Appetite and Energy Intake
NCT07050017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The participants will report to the research facility between 7 - 9 am to complete each 4-h testing day. Prior to testing, the participants will be provided with a standardized dinner to consume, at home, between 5-7 pm the night before each testing day. Upon arrival to the facility, each participant will become familiarized with the testing day procedures. At time -15 min, a baseline set of computerized questionnaires will be completed. At time 0 min, one of the breakfast beverages will be provided. Immediately following the first swallow of the breakfast shakes, the participants will be given a questionnaire assessing the palatability of each shake. The participants will consume the beverage within 20 min. For 5 of the 6 days, a set of questionnaires will be completed every 30 min throughout the 4-h postprandial period. For one of the W days, no questionnaires will be completed. After the 4-h, the participants will be given an ad libitum pasta meal to assess energy intake. For the lunch meal, the participants will be given 30 min to "consume as much or as little as possible until comfortably full." Following these procedures, the participants will be allowed to leave the facility. The next day, a dietary recall will be performed to assess daily energy intake following the consumption of the previous day's breakfast beverage.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breakfast Preload Drink
Participants were given isovolumetric drinks, to consume in the morning after an overnight fast, followed by questionnaires asking throughout the day asking participants of their perceived hunger, fullness, desire to eat, and prospective food consumption, and if they would like to eat again. Four hours following consumption, they were given an ad libitum pasta meal to consume.
The drinks consisted of the following:
Water Preload Drink, Whey Protein Isolate Drink, Micellar Casein Protein Drink, Egg White Isolate Protein Drink, and Egg White Concentrate Protein Drink
Water Preload Drink
Participants were given 275 ml (0 kcal) water to consume in the morning following an overnight fast. This served as the control drink.
Whey Protein Isolate Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g whey protein to consume in the morning following an overnight fast.
Micellar Casein Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g micellar casein to consume in the morning following an overnight fast.
Egg White Isolate Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g egg white isolate protein to consume in the morning following an overnight fast.
Egg White Concentrate Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g egg white concentrate protein to consume in the morning following an overnight fast.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water Preload Drink
Participants were given 275 ml (0 kcal) water to consume in the morning following an overnight fast. This served as the control drink.
Whey Protein Isolate Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g whey protein to consume in the morning following an overnight fast.
Micellar Casein Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g micellar casein to consume in the morning following an overnight fast.
Egg White Isolate Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g egg white isolate protein to consume in the morning following an overnight fast.
Egg White Concentrate Protein Drink
Participants were given an isovolumetric (to the water), 160 kcal drink with 30 g egg white concentrate protein to consume in the morning following an overnight fast.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ages 18-35 years old
3. normal weight to overweight (BMI: 18.5-29.9 kg/m2)
4. no metabolic, psychological, or neurological diseases/conditions
5. weight stable (no weight loss/gain within the past 6 mo)
6. not currently on a weight loss or other special diet (in the past 6 mo)
7. not a vegetarian
8. not pregnant
9. non-smoker
Exclusion Criteria
2. ages \<18 or \>35 years old
3. underweight or obese (BMI: \<18.5 or \>29.9 kg/m2)
4. metabolic, psychological, or neurological diseases/conditions
5. not weight stable (weight loss/gain within the past 6 mo)
6. Currently on a weight loss or other special diet (in the past 6 mo)
7. A vegetarian; 8) pregnant; and 9) smoker
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heather Leidy
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MU2005830
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.